Skip to content
  • About
  • Events
  • Advocacy
  • Coalitions
  • About
  • Events
  • Advocacy
  • Coalitions
Facebook-square Icon-twitter-x Youtube
  • About
  • Events
  • Advocacy
  • Coalitions
  • About
  • Events
  • Advocacy
  • Coalitions

Tag: Cardiovascular|Cost Value

Comments on ICER’s Draft Evidence Report: High Cholesterol Therapies

Effective treatments that reduce the risk factors associated with ASCVD offers tremendous value to the patient community. Read the Letter

ICER Report Could Intensify Barriers for Heart Patients

Accessing innovative cardiovascular drugs may soon get harder.

  • STATE CHAPTERS
  • GLOBAL AFPA
  • INSTITUTE FOR PATIENT ACCESS
  • CONTACT US
  • STATE CHAPTERS
  • GLOBAL AFPA
  • INSTITUTE FOR PATIENT ACCESS
  • CONTACT US
Subscribe to our newsletter

© 2024, Alliance for Patient Access.

Website Management provided by Genacom
2020 K Street NW, Suite 505 Washington, DC 20006
[email protected]
(202) 951-7097
Facebook-square Icon-twitter-x Youtube